| European Case Law Identifier: | ECLI:EP:BA:2009:T143707.20091026 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 26 October 2009 | ||||||||
| Case number: | T 1437/07 | ||||||||
| Application number: | 99203735.8 | ||||||||
| IPC class: | A61K 38/16 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Botulinum toxins A or B for treating pain associated with smooth muscle spasms | ||||||||
| Applicant name: | Allergan, Inc. | ||||||||
| Opponent name: | Solstice Neurosciences, Inc. Ipsen Pharma S.A.S. |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Main request - novelty (no) Auxiliary request - added matter, extension of scope (no); sufficiency of disclosure, novelty, inventive step (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t071437eu1.html
Date retrieved: 17 May 2021